LEADER 02350nam 2200493 450 001 9910798616803321 005 20170718085336.0 010 $a0-309-44360-1 010 $a0-309-44358-X 035 $a(CKB)3710000000865223 035 $a(MiAaPQ)EBC4690555 035 $a(EXLCZ)993710000000865223 100 $a20161006h20162016 uy| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 10$aStrategies for ensuring diversity, inclusion, and meaningful participation in clinical trials $eproceedings of a workshop /$fKaren M. Anderson and Steve Olson, rapporteurs ; Roundtable on the Promotion of Health Equity and the Elimination of Health Disparities, Board on Population Health and Public Health Practice, Health and Medicine Division, The National Academies of Sciences, Engineering, Medicine 210 1$aWashington, DC :$cThe National Academies Press,$d[2016] 210 4$dİ2016 215 $a1 online resource (85 pages) $cillustrations (some color) 311 $a0-309-44357-1 320 $aIncludes bibliographical references. 327 $aIntroduction and highlights of the workshop -- Historical perspectives and context -- Scientific issues : clinically meaningful inclusion -- Recruitment and retention issues : patient, provider, institutional, and system barriers -- Potential best practices and policy options. 606 $aClinical trials$zUnited States$vCongresses 606 $aMinorities$zUnited States 606 $aWomen$zUnited States 615 0$aClinical trials 615 0$aMinorities 615 0$aWomen 676 $a616.84982 700 $aAnderson$b Karen M.$01094210 702 $aAnderson$b Karen M. 702 $aOlsen$b Steven 712 02$aNational Academies of Sciences, Engineering, and Medicine (U.S.).$bRoundtable on the Promotion of Health Equity and the Elimination of Health Disparities, 712 12$aStrategies for Ensuring Diversity, Inclusion, and Meaningful Participation in Clinical Trials (Workshop)$f(2015 :$eWashington, D.C.), 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910798616803321 996 $aStrategies for ensuring diversity, inclusion, and meaningful participation in clinical trials$93800488 997 $aUNINA